The American Psychiatric Association proposed incorporating biomarkers into future editions of its Diagnostic and Statistical Manual of Mental Disorders to improve mental health diagnoses and treatments. This move could lead to more accurate and faster diagnoses, potentially reducing trial-and-error prescribing and unnecessary medication use, but requires further research and validation before widespread implementation.
Read the full article at KFF Health News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



